Loading...

Double blind study of ispaghula in irritable bowel syndrome.

A double blind placebo controlled trial of ispaghula husk in 80 patients with irritable bowel syndrome is reported. Global assessment judged treatment to be satisfactory in 82% of patients receiving ispaghula and 53% of the placebo group (p less than 0.02). Bowel habit was unchanged in the placebo g...

Full description

Saved in:
Bibliographic Details
Main Authors: Prior, A, Whorwell, P J
Format: Artigo
Language:Inglês
Published: 1987
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1433676/
https://ncbi.nlm.nih.gov/pubmed/3322956
Tags: Add Tag
No Tags, Be the first to tag this record!